Possibility of the Low Defensive Fibrinolysis in SHRSP
スポンサーリンク
概要
著者
-
Saito Naohiro
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Koide Takashi
Tokyo Research Laboratories Kowa Co. Ltd.
-
Nakajima Katsuaki
Tokyo Research Laboratories Kowa Company Ltd.
-
Ueda Hideo
Sakakibara Heart Institute
-
Suzuki Hideo
Tokyo New Drug Research Laboratories I Pharmaceutical Division Kowa Co Ltd
-
Kimata Hideki
Tokyo Research Laboratories, Kowa Co. Ltd.
-
Nakajima Katsuaki
Tokyo Research Laboratories, Kowa Co. Ltd.
-
Koide Takashi
Tokyo Research Laboratories, Kowa Co. Ltd.
-
Suzuki Hideo
Tokyo Research Laboratories, Kowa Co. Ltd.
関連論文
- Abrogation of Bronchial Eosinophilic Inflammation and Attenuated Eotaxin Content in Protease-Activated Receptor 2-Deficient Mice
- Effect of Protease-Activated Receptor-2 Deficiency on Allergic Dermatitis in the Mouse Ear
- Importance of Sialic Acid in Recombinant Thrombomodulin in Terms of Pharmacokinetics and Separation of Desialyzed Glycoprotein
- Increased Anticoagulant Activity of Recombinant Thrombomodulin Modified with Glycosaminoglycan
- Binding of Human Tissue Plasminogen Activator (t-PA) to Blood Clots and Clot-Lytic Activity of Clot-Bound t-PA
- Dehydroxy Substitution Reactions of the Anomeric Hydroxy Groups in Some Protected Sugars Initiated by Anodic Oxidation of Triphenylphosphine
- Fluorination of Secondary and Primary Alcohols by Thermal Decomposition of Electrochemically Generated Alkoxy Triphenylphosphonium Tetrafluoroborates
- Plaque-Stabilizing Effect of Pitavastatin in Watanabe Heritable Hyperlipidemic (WHHL) Rabbits
- Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection
- Identification of Metabolites of NK-104,an HMG-CoA Reductase Inhibitor, in Rat, Rabbit and Dog Bile
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (2) : Absorption, Distribution, Metabolism, Excretion and Accumulation Following Repeated Oral Administration of ^C-NK-104 in Rats
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (1) : Absorption, Distribution, Metabolism and Excretion in Rats
- Thrombolytic Effect of Tissue Plasminogen Activator in a Cerebral Embolic Model
- Localization of Tissue Plasminogen Activator on Experimental Microthrombi in Rats. Microautoradiographic Observations
- Localization of Tissue Plasminogen Activator on Experimental Thrombi in Rats
- Defect of Delta-Sarcoglycan Gene Is Responsible for Development of Dilated Cardiomyopathy of a Novel Hamster Strain, J2N-k : Calcineurin/PP2B Activity in the Heart of J2N-k Hamster
- EFFECTS OF DILAZEP ON FIBRINOLYTIC SYSTEM IN ANIMALS. II. ENHANCING EFFECT OF DILAZEP ON PLASMINOGEN ACTIVATOR RELEASE IN THE ISOLATED PERFUSED PIG EAR
- EFFECTS OF DILAZEP ON FIBRINOLYTIC SYSTEM IN ANIMALS. I. ENHANCEMENT OF FIBRINOLYTIC ACTIVITY BY ADMINISTERED DILAZEP IN EX VIVO EXPERIMENT
- CLINICAL AND ELECTROPHYSIOLOGIC CHARACTERISTICS OF LIFE-THRETENING VENTRICULAR TACHYARRHYTHMIAS OCCURRING DURING TREADMILL EXERCISE TESTING : Exercise Test, Rehabilitation : 53 Annual Scientific Meeting, Japanese Circulation Society
- Effects of Salt-loading on the Onset of Stroke and the Development of Cerebral Lesions in SHRSP
- Venous Distensibility in Stroke-Prone SHR at 6 and 15 Weeks of Age---Comparison with Age-Matched WKY---
- Possibility of the Low Defensive Fibrinolysis in SHRSP
- Potential effectiveness of minidose aspirin combined with dilazep in anti-platelet therapy.
- Effects of beta-blockers upon the blood pressure, mortality and cerebral injury in the salt-loaded SHRSP
- The Blood Pressure, Life Span, Body Weight in Both Sexes of SHRSP during 55 Weeks under Specific Pathogen Free System
- The Heart Failure and Myocardial Changes of SHRSP derived from Non-stroke Parents under Specific Pathogen-free System
- Ultrastructural Changes of the Myocardium of SHRSP derived from the parents of Cardiac Death under Specific Pathogen-Free System
- Effects of Salt and Beta-Blocker (Nipradilol and Propranolol) on Blood Pressure and Renal Histology of SHR (SHRSR, SHRSP and SHRHP)